AMERICAN JOURNAL OF HYPERTENSION

Scope & Guideline

Exploring innovative solutions for cardiovascular wellness.

Introduction

Immerse yourself in the scholarly insights of AMERICAN JOURNAL OF HYPERTENSION with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN0895-7061
PublisherOXFORD UNIV PRESS
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Converge1954, from 1988 to 2024
AbbreviationAM J HYPERTENS / Am. J. Hypertens.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressGREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND

Aims and Scopes

The American Journal of Hypertension primarily focuses on advancing the understanding, diagnosis, and treatment of hypertension through innovative research and clinical insights. It serves as a platform for high-quality studies that explore a wide range of topics related to hypertension, including its pathophysiology, epidemiology, treatment strategies, and the impact of social determinants on hypertension management.
  1. Clinical Research and Trials:
    The journal emphasizes original clinical research and randomized controlled trials that provide evidence-based insights into hypertension management and treatment efficacy.
  2. Pathophysiological Mechanisms:
    Investigations into the biological and physiological mechanisms underlying hypertension, including studies on vascular function, renal mechanisms, and hormonal influences.
  3. Epidemiology and Public Health:
    Research on the prevalence, risk factors, and socio-economic determinants of hypertension, aiming to inform public health strategies and interventions.
  4. Innovative Treatment Approaches:
    Exploration of novel pharmacological and non-pharmacological treatment options for hypertension, including lifestyle modifications and new drug classes.
  5. Technological Advancements:
    Integration of technology in hypertension management, such as telemonitoring, mobile health applications, and wearable devices for blood pressure monitoring.
  6. Health Disparities:
    Focus on understanding and addressing racial, ethnic, and socio-economic disparities in hypertension prevalence and management.
The American Journal of Hypertension has been evolving, with several emerging themes gaining traction in recent publications. These trends reflect a broader understanding of hypertension's complexities and a more holistic approach to its management.
  1. Multifactorial Approaches to Hypertension Management:
    An increasing number of studies focus on the interplay of genetic, environmental, and lifestyle factors in hypertension, emphasizing a multifaceted approach to treatment.
  2. Impact of Social Determinants of Health:
    Research highlighting the influence of social determinants, such as socioeconomic status and access to care, on hypertension outcomes is becoming more prominent.
  3. Hypertension in Special Populations:
    Emerging studies are focusing on hypertension in specific populations, including pregnant women, children, and ethnic minorities, addressing unique challenges and treatment responses.
  4. Technological Integration in Hypertension Care:
    There is a growing interest in the use of digital health technologies, such as telehealth and mobile health applications, to enhance hypertension management and patient engagement.
  5. Comorbidities and Hypertension:
    The relationship between hypertension and other chronic conditions, such as diabetes and cardiovascular diseases, is increasingly being explored, emphasizing comprehensive patient management.
  6. Patient-Centered Care and Experiences:
    Research focusing on patient experiences, preferences, and adherence to hypertension treatment is gaining traction, reflecting a shift towards more personalized care.

Declining or Waning

While the American Journal of Hypertension has a robust focus on various aspects of hypertension research, certain themes appear to be declining in prominence over recent years. This decline may reflect shifts in research interests or emerging priorities within the field.
  1. Traditional Pharmacological Approaches:
    There has been a noticeable decrease in studies solely focusing on traditional antihypertensive medications, as newer treatment strategies and combination therapies gain attention.
  2. Static Risk Factor Analysis:
    Research that solely addresses static risk factors for hypertension, such as age and BMI, is becoming less common, with a shift toward more dynamic and multifactorial approaches.
  3. Basic Science Studies:
    There is a waning interest in purely basic science research without direct clinical implications, as the journal increasingly prioritizes translational and clinical research.
  4. Longitudinal Cohort Studies:
    Although still valuable, there appears to be a decrease in the publication of large longitudinal cohort studies that focus solely on hypertension without incorporating intervention strategies.

Similar Journals

CURRENT HYPERTENSION REPORTS

Advancing understanding in hypertension management.
Publisher: SPRINGERISSN: 1522-6417Frequency: 12 issues/year

CURRENT HYPERTENSION REPORTS is a premier journal dedicated to advancing the field of cardiovascular health, particularly focusing on hypertension and its multifaceted implications. Published by SPRINGER, this influential journal boasts an impressive impact factor and ranks in the top Q1 category among Internal Medicine journals, placing it within the elite 88th percentile of its field according to Scopus rankings. Since its inception in 1999, it has provided a platform for cutting-edge research and clinical insights, facilitating knowledge exchange among researchers, healthcare professionals, and students alike. With a commitment to publishing high-quality articles without open access barriers, CURRENT HYPERTENSION REPORTS remains an essential resource for those looking to stay abreast of the latest developments and trends in hypertension management and treatment.

JOURNAL OF HYPERTENSION

Your premier source for cutting-edge cardiovascular research.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0263-6352Frequency: 12 issues/year

JOURNAL OF HYPERTENSION, published by Lippincott Williams & Wilkins, stands at the forefront of cardiovascular research, serving as a premier platform for the dissemination of knowledge in hypertension and related cardiovascular conditions. With an impressive impact factor, this esteemed journal is recognized in Q1 quartile across multiple categories, including Cardiology, Internal Medicine, and Physiology as of 2023, firmly establishing its significance within the academic community. The journal has been a reliable source of cutting-edge research since its inception in 1983, with continued publication through 2024. Researchers can expect a rigorous peer-review process and a diverse array of articles that include original research, reviews, and clinical studies aimed at enhancing the understanding and management of hypertension. Although it is not an open-access journal, the JOURNAL OF HYPERTENSION remains invaluable to clinicians, researchers, and students dedicated to advancing the field of cardiovascular health.

Pulmonary Circulation

Advancing knowledge in pulmonary health.
Publisher: WILEYISSN: 2045-8932Frequency: 4 issues/year

Pulmonary Circulation is a leading open-access journal published by Wiley, focused on advancing the field of pulmonary and respiratory medicine. Established in 2011, the journal has garnered a prestigious reputation, achieving a Q2 ranking in 2023 among its category and ranking #70 out of 155 in Scopus within the specialty of Medicine – Pulmonary and Respiratory Medicine, reflecting its growing influence and relevance in the scientific community. With its commitment to delivering high-quality, peer-reviewed research, Pulmonary Circulation serves as a vital resource for researchers, clinicians, and students seeking to explore innovative ideas and findings in lung health, pulmonary vascular diseases, and therapeutic approaches. The journal has been open access since 2017, ensuring that groundbreaking research is accessible to a wider audience, thus promoting collaboration and knowledge exchange in this dynamic field. Located in the heart of the United States at 111 River St, Hoboken, NJ 07030-5774, the journal is dedicated to fostering advancements in pulmonary health and addressing real-world challenges facing patients globally.

Russian Open Medical Journal

Unlocking innovative solutions in the realm of medicine.
Publisher: SCIENCE & INNOVATION, LTDISSN: 2304-3415Frequency: 4 issues/year

Russian Open Medical Journal is an esteemed academic publication launched in 2012 by SCIENCE & INNOVATION, LTD, dedicated to advancing the field of medicine and promoting innovative research. As an Open Access journal, it ensures that knowledge is freely accessible to all, fostering collaboration and dissemination of vital medical findings. Based in the Russian Federation, this journal covers a wide array of topics under the domain of general medicine and contributes to the global medical discourse with its commitment to quality research dissemination. With a current Scopus rank of #368 out of 636 in the category of General Medicine, placing it in the 42nd percentile, the journal demonstrates a growing impact within the scientific community. Researchers, healthcare professionals, and students seeking to explore contemporary medical issues will find this journal a valuable resource, reflecting a global perspective while emphasizing innovative solutions to health challenges.

Arterial Hypertension

Fostering collaboration in the fight against arterial hypertension.
Publisher: VIA MEDICAISSN: 2449-6170Frequency: 4 issues/year

Arterial Hypertension is a dedicated Open Access journal published by VIA MEDICA, with the ISSN 2449-6170 and E-ISSN 2449-6162, focusing on the multidisciplinary field of cardiology, endocrinology, and internal medicine. Established in Poland, this journal has been providing researchers and healthcare professionals with accessible, high-quality content since its inception in 1999. With a commitment to advancing knowledge in the management and treatment of arterial hypertension, it publishes significant research findings, clinical trials, and reviews that contribute to improved health outcomes. Though classified in Q4 across various relevant categories, the continuous improvement in its content ensures its relevance in an evolving medical landscape. Designed to facilitate collaboration and innovation, Arterial Hypertension serves as a crucial resource for anyone invested in cardiovascular health, encouraging open dialogue and dissemination of vital research within the scientific community.

Pregnancy Hypertension-An International Journal of Womens Cardiovascular Health

Exploring the Intersection of Pregnancy and Cardiovascular Wellness
Publisher: ELSEVIER SCI LTDISSN: 2210-7789Frequency: 4 issues/year

Pregnancy Hypertension – An International Journal of Women's Cardiovascular Health, published by Elsevier Science Ltd, is a leading platform dedicated to advancing the understanding of cardiovascular health in women during pregnancy and postpartum periods. With an ISSN of 2210-7789, this esteemed journal has distinguished itself in the fields of Internal Medicine and Obstetrics and Gynecology, maintaining a remarkable Q2 ranking in Internal Medicine and a prestigious Q1 ranking in Obstetrics and Gynecology as of 2023. It is recognized for its high-quality research, which fits within the top quartile of its categories, and spans from 2010 to 2024, reflecting its ongoing contribution to critical advancements in women's cardiovascular health. The journal is accessible to a global audience of researchers, practitioners, and students, emphasizing its commitment to promoting open scholarly communication, although it currently operates under traditional access. The publication serves as a crucial resource for those seeking to enhance their knowledge and practices related to the unique cardiovascular challenges faced by women during pregnancy, thereby fostering informed clinical approaches and improved health outcomes.

Current Hypertension Reviews

Advancing Insights in Hypertension Management
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1573-4021Frequency:

Current Hypertension Reviews, published by Bentham Science Publishers Ltd, stands as a leading journal in the field of internal medicine, particularly focusing on hypertension and related cardiovascular disorders. With an impressive impact factor and ranked #59 out of 167 in the Scopus medicine category, this journal highlights key insights and contemporary research trends from its inception in 2006 to 2024. Its commitment to making high-quality research accessible to the medical community, despite lacking an Open Access option, ensures that it continues to contribute significantly to the scientific discourse surrounding hypertension management and innovative treatments. Researchers, clinicians, and students alike will find valuable resources within its pages, as Current Hypertension Reviews plays a critical role in advancing the understanding and treatment of hypertension, ultimately supporting better health outcomes globally.

Neuropsychiatric Disease and Treatment

Fostering Global Collaboration in Neuropsychiatric Research
Publisher: DOVE MEDICAL PRESS LTDISSN: Frequency: 1 issue/year

Neuropsychiatric Disease and Treatment, published by DOVE MEDICAL PRESS LTD, is a prominent open access journal dedicated to advancing the field of neuropsychiatry. Since its inception in 2009, this journal has provided a platform for the dissemination of high-quality research on innovative therapies and treatments for neuropsychiatric disorders. With an impressive Q2 ranking in Psychiatry and Mental Health and a Q3 ranking in Biological Psychiatry as of 2023, it holds a reputable position within the scholarly community, reflecting its commitment to impactful research. The journal's open access model ensures widespread accessibility, fostering collaboration and dialogue among researchers, clinicians, and students worldwide. The journal accepts a variety of article types, including original research, reviews, and case studies, encompassing a range of topics from pathophysiology to therapeutic advancements. With its base in New Zealand and a Scopus rank placing it within the 69th percentile of Psychiatry and Mental Health, Neuropsychiatric Disease and Treatment is an essential resource for those dedicated to understanding and treating the complexities of neuropsychiatric conditions.

Advances in Rheumatology

Bridging gaps in knowledge for better patient care in rheumatology.
Publisher: BMCISSN: 2523-3106Frequency: 1 issue/year

Advances in Rheumatology is a premier open-access journal published by BMC, dedicated to advancing the field of rheumatology through high-quality, peer-reviewed research. Launched in 2018, the journal has quickly established itself within the academic community, achieving a commendable Q2 ranking in the category of Rheumatology as of 2023 and ranking #34 out of 73 in the Scopus Medicine Rheumatology listings, placing it in the 54th percentile. With a focus on innovative treatments, patient care, and the latest in rheumatological research, the journal provides a platform for researchers and clinicians to disseminate their findings and foster collaborative advancements in this critical area of medicine. Recognized for its accessibility, the journal follows an open-access model, ensuring that research is freely available to a global audience. With a commitment to high standards of academic rigor, Advances in Rheumatology plays a vital role in enhancing the understanding and treatment of rheumatic diseases, making it an invaluable resource for researchers, professionals, and students alike.

JAMA Cardiology

Shaping the Future of Cardiology with Rigorous Science.
Publisher: AMER MEDICAL ASSOCISSN: 2380-6583Frequency: 12 issues/year

JAMA Cardiology, published by the American Medical Association, is a leading peer-reviewed journal in the field of cardiology and cardiovascular medicine, with an impressive impact factor signifying its influence and relevance within the medical community. Established in 2016, this journal has quickly gained recognition, currently positioned in the Q1 quartile and ranked #2 out of 387 in its field according to Scopus, reflecting its commitment to high-quality research dissemination. As an esteemed publication, JAMA Cardiology aims to advance the understanding of cardiovascular health through rigorous studies, reviews, and clinical insights. The journal is dedicated to serving a diverse audience of researchers, clinicians, and students, ensuring they have access to groundbreaking findings and comprehensive discussions that shape contemporary cardiology. Although it is not an open-access journal, articles published within it play a pivotal role in informing clinical practice and guiding future research in cardiovascular health, making it an essential resource for anyone engaged in this vital field.